secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2025-02-05T23:59:59+00:00
Accession:  0001558370-25-000639
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q2 organic revenue +9% to $297M, adjusted EPS $0.42; declares $0.08 dividend
--------------------------------------------------------------------------------

- Q2 organic revenue up 9% to $297.0M; GAAP EPS $0.22 vs $0.17, adjusted EPS $0.42 vs $0.40.
- Protein Sciences segment grew 8% organic; Diagnostics & Spatial Biology grew 12% organic.
- Declared $0.08 per share quarterly dividend, payable Feb 28, 2025 to holders of record Feb 17, 2025.
- Dr. Amy Herr appointed independent director effective Feb 1, 2025; serves on Science & Technology Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837025000639/0001558370-25-000639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837025000639/tech-20250130x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-000639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer